Suboptimale resultater blev opnået for børn i alderen 1- 11 år, og resultaterne vedrørende farmakodynamik samt virkning gør det vanskeligt at anbefale doseringer.
Sub-optimal results were obtained for children 1-11 years of age and pharmacodynamic as well as the efficacy results make dosing recommendations difficult.